Chronic localized pain, the kind that stays stubbornly in one spot regardless of what you try, is one of the most difficult pain presentations to treat effectively. DRG stimulation was developed specifically to solve this problem, offering a level of targeting precision that conventional spinal cord stimulation simply cannot match.
What Is the Dorsal Root Ganglion?
Understanding the anatomy that makes DRG stimulation so precise.
The dorsal root ganglion, or DRG, is a small cluster of nerve cell bodies located just outside the spinal canal, at the point where each spinal nerve exits the vertebral column. Every level of the spine, from the cervical region down to the sacrum, has its own pair of DRGs, one on each side. These ganglia act as the body’s sensory relay stations, processing and transmitting information about pain, temperature, and touch from a specific region of the body to the brain.
What makes the DRG so important in the context of pain management is its anatomical specificity. Each DRG corresponds to a defined territory of the body, known as a dermatome. The DRG at the L4 level, for example, processes sensory input from a specific region of the lower leg and foot. This means that by modulating the activity of a single DRG, a pain specialist can selectively influence pain signals coming from a very precise area of the body.
In chronic pain conditions, DRG neurons can become hyperexcitable, firing spontaneously and amplifying pain signals even in the absence of ongoing tissue damage. This is a key mechanism underlying conditions like complex regional pain syndrome, post-surgical nerve pain, and neuropathic pain following injury. DRG stimulation targets this abnormal neuronal activity directly at the source.
How DRG Stimulation Differs From Spinal Cord Stimulation
Both are neuromodulation therapies, but they work in fundamentally different ways.
Spinal cord stimulation (SCS) has been used for chronic pain management for over 50 years. It works by delivering electrical impulses to the dorsal columns of the spinal cord, creating a broad pattern of coverage that can be effective for diffuse back or leg pain. DRG stimulation is a newer, more targeted approach that delivers stimulation directly to individual ganglia, allowing for much tighter anatomical control.
🎯 DRG Stimulation
- Targets a specific ganglion at a defined spinal level
- Highly effective for focal, localized pain
- Stable lead placement with low migration rates
- Less positional variation in stimulation effect
- Superior outcomes for foot and ankle pain
- FDA-approved for CRPS Types I and II
⚡ Spinal Cord Stimulation
- Covers broader areas of the back and legs
- Better suited for diffuse, widespread pain
- Longer track record and wider availability
- Stimulation can shift with body position
- Multiple waveform options available
- Approved for a wider range of indications
Which Conditions Respond Best to DRG Stimulation?
DRG therapy is particularly effective for focal neuropathic pain that has not responded to other treatments.
Complex Regional Pain Syndrome (CRPS)
The FDA-approved primary indication. DRG stimulation consistently outperforms SCS for CRPS affecting the foot and ankle.
Post-Surgical Nerve Pain
Persistent neuropathic pain following spine surgery, hernia repair, knee replacement, or other procedures.
Foot and Ankle Pain
Notoriously difficult to cover with conventional SCS, foot and ankle pain responds exceptionally well to DRG targeting.
Peripheral Neuropathy
Focal neuropathic pain from nerve injury or entrapment that corresponds to a specific dermatomal territory.
Groin and Pelvic Pain
Chronic pain in the groin, inner thigh, or pelvis region often maps to specific lumbar and sacral DRG levels.
Failed Conservative Treatment
Patients who have not achieved adequate relief from medications, injections, or physical therapy for localized nerve pain.
How the DRG Stimulation Procedure Works
A step-by-step overview from evaluation through permanent implant.
Comprehensive Evaluation and Patient Selection
Your CURA pain specialist begins with a detailed review of your pain history, prior treatments, imaging studies, and physical examination. The goal is to confirm that your pain is clearly localized to a dermatomal territory that can be targeted with DRG stimulation, and that you have not achieved adequate relief from appropriate conservative therapies. Psychological screening is also typically performed as part of the pre-implant evaluation.
Trial Stimulation Period
Before a permanent device is implanted, a trial stimulation period of 5 to 10 days is performed. During the trial, temporary leads are placed under fluoroscopic guidance and positioned at the DRG levels corresponding to your pain area. The leads are connected to an external pulse generator worn outside the body. If you achieve at least 50% reduction in your pain during the trial, you are considered a good candidate for a permanent implant.
Lead Placement Under Fluoroscopic Guidance
DRG lead placement is a technically precise procedure performed under real-time fluoroscopic imaging. The physician guides a specialized catheter-based lead through the epidural space to the intervertebral foramen, where the DRG is located. Because the DRG sits in a bony recess, the lead anchors naturally in place, resulting in significantly lower lead migration rates compared to conventional spinal cord stimulation leads placed along the dorsal columns.
Permanent Implant and Generator Placement
If the trial is successful, a permanent implant procedure is scheduled. The definitive leads are placed at the same target levels, and a small implantable pulse generator (IPG) is placed subcutaneously, typically in the upper buttock or lower abdomen. The IPG powers the stimulation and can be programmed and adjusted wirelessly using a handheld controller, allowing the patient and physician to fine-tune the therapy over time.
Programming and Long-Term Follow-Up
After the permanent implant, your CURA physician will work with you to optimize stimulation parameters for maximum pain relief. Programming sessions allow adjustment of amplitude, frequency, pulse width, and the specific combination of electrode contacts activated. Most patients achieve stable, long-term relief with periodic programming adjustments as needed. The device battery typically lasts several years depending on usage, after which the IPG can be replaced in a minor outpatient procedure.
Frequently Asked Questions
Common questions about DRG stimulation answered by our board-certified pain specialists.
A nerve block delivers medication, typically an anesthetic or steroid, to temporarily interrupt or reduce nerve signaling. The effects are temporary and wear off over hours, days, or weeks depending on the agent used. DRG stimulation, by contrast, is an ongoing neuromodulation therapy that delivers continuous low-level electrical impulses to modify how the DRG processes pain signals. It does not involve injecting medication and its effects are sustained as long as the device is active. For patients who respond well to nerve blocks but experience only temporary relief, DRG stimulation can provide a longer-lasting solution.
DRG stimulation can be programmed to deliver sub-perception stimulation, meaning many patients feel little or nothing at all while the device is active. This is a significant advantage over older spinal cord stimulation systems, which often produced a tingling or buzzing sensation called paresthesia. Some patients prefer a mild paresthesia as confirmation that the therapy is active, and the system can be adjusted accordingly. The absence of positional paresthesia changes is another key benefit, as the stimulation effect remains consistent whether you are sitting, standing, or lying down.
Yes. DRG stimulation is fully reversible. The device can be turned off at any time, and the implanted hardware can be surgically removed if the patient no longer wishes to continue therapy or if circumstances change. Because the procedure does not involve ablating or permanently damaging any tissue, reversal is straightforward. This reversibility, combined with the mandatory trial period, makes DRG stimulation a low-risk option for appropriately selected patients who have exhausted other treatments for their localized nerve pain.
This depends on the specific device implanted. The Abbott Proclaim DRG system, the primary FDA-approved DRG stimulator available in the United States, has conditional MRI compatibility. This means that under specific conditions and settings, MRI scans of certain body regions can be performed safely. Your CURA physician will discuss the specific MRI compatibility parameters of the device being used and ensure that any necessary imaging can be performed safely after implantation.
DRG stimulation is FDA-approved for complex regional pain syndrome (CRPS) Types I and II, and coverage for this indication is available through Medicare and many major commercial insurers including Aetna, Cigna, Horizon BCBS, and UnitedHealthcare. Coverage for other indications varies by payer and typically requires documentation of a specific diagnosis, confirmed failure of conservative treatments, and a successful trial stimulation period. CURA’s team will conduct a thorough insurance verification before proceeding to ensure you have a clear understanding of your coverage and any out-of-pocket costs.
If your trial is successful, the permanent implant procedure is typically scheduled within a few weeks, depending on insurance authorization timelines and scheduling availability. The permanent procedure itself is performed on an outpatient basis and takes approximately 1 to 2 hours. Most patients are able to return home the same day and resume light daily activities within a few days, with more strenuous activity restricted for 4 to 6 weeks to allow the implant site to heal properly.
